Autolus Therapeutics Director William Young Receives Equity Awards

Autolus Therapeutics plc director William D. Young received equity awards on June 29, 2026, as disclosed in this Form 4 filing. Young was granted 31,667 restricted share units (RSUs) that vest in one installment on June 29, 2027, and 47,500 share options with an exercise price of $1.61 per share that vest in twelve equal monthly installments beginning July 29, 2026. Both awards are convertible into American Depositary Shares, with each ADS representing one ordinary share of the company. The RSUs were granted at $0 per share, representing future compensation that will convert to equity upon vesting. Following these transactions, Young holds 31,667 RSUs and 47,500 share options. The filing was signed on July 1, 2026, and reflects standard director compensation through equity awards.